The short version of NAD+ fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-04-12. Anything still debated is marked as such rather than presented as settled.
Quality control for NMN typically checks identity, assay purity, residual solvents, heavy metals, and microbial limits, depending on the intended use and market. A certificate of analysis may report appearance, solubility, water content, and storage recommendations. Independent verification can compare chromatographic retention time and mass spectrum against a certified reference standard. Regulatory expectations differ between research chemicals, dietary ingredients, and pharmaceutical products. Impurity profiles and stability data are often requested for product approval, and open questions remain about how best to standardize NMN measurements across laboratories.
NMN is a polar, water-soluble nucleotide. In solid form it is usually a white to off-white powder. The compound is sensitive to heat, light, moisture, and extremes of pH, and aqueous solutions tend to degrade faster than dry material. Recommended storage for research samples is typically -20 °C or below in a sealed, desiccated container protected from light. Repeated freeze-thaw cycles should be avoided, and these handling practices help maintain identity and purity during laboratory use.
Analytical identification of NMN commonly uses high-performance liquid chromatography with ultraviolet detection, liquid chromatography-mass spectrometry, and nuclear magnetic resonance spectroscopy; HPLC can estimate purity by peak area, while mass spectrometry confirms molecular mass and fragmentation. NMR provides structural confirmation. Because NMN is charged, ion-pairing reagents or hydrophilic interaction liquid chromatography columns can improve retention and peak shape. In biological samples, LC-MS/MS with stable isotope internal standards is often used to quantify NMN and related NAD+ metabolites. Method validation is important because matrix effects and rapid enzymatic interconversion can complicate measurements.
NMN is present in small amounts in various foods, including certain vegetables, fruits, and milk, though dietary quantities are generally low. Laboratory research often uses synthetic or enzymatically produced NMN. The compound has drawn interest because NAD+ levels decline with age in some tissues and because restoring NAD+ may affect metabolism in animal models. Whether oral NMN produces meaningful NAD+ increases in humans and whether such changes translate into health benefits are not fully established.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide. Its structure combines a nicotinamide base with a ribose sugar and a phosphate group. Within cells, NMN sits on the biosynthetic route that recycles nicotinamide back into nicotinamide adenine dinucleotide, or NAD+. Because NAD+ participates in redox reactions and signaling, enzymes that produce and consume it influence many metabolic processes. The compound is therefore best described as an intermediate rather than a final signaling molecule.
In the canonical salvage pathway, nicotinamide phosphoribosyltransferase, known as NAMPT, transfers a phosphoribosyl group to nicotinamide and releases NMN. A second enzyme, NMN adenylyltransferase, then attaches an adenylyl group to NMN to form NAD+. Alternative routes exist, including a pathway that uses nicotinamide riboside and its phosphorylated forms. The relative contribution of extracellular NMN to intracellular NAD+ pools remains an area of active investigation, and the roles of specific transporters and enzymes are not completely defined.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typical for solid free acid or salt forms |
| Solubility | Freely soluble in water | Polar nucleotide; limited solubility in nonpolar solvents |
| Typical storage | -20 °C or below | Desiccated, protected from light |
| Common analytical method | LC-MS or HPLC-UV | Used for identity and purity assessment |
| Common synonyms | Nicotinamide ribonucleotide; beta-NMN | NMN is the usual abbreviation |
Quality control for NMN materials usually covers identity, assay purity, residual solvents, heavy metals, microbial limits, and moisture content. Certificates of analysis from suppliers may report high-performance liquid chromatography purity, mass spectrometry identity, and elemental impurity testing. Regulatory treatment differs by country: NMN is not an approved drug, and its status as a dietary supplement ingredient or novel food has been debated. Some authorities have restricted sales pending safety and regulatory review, while others allow it under specific categories. Buyers should verify documentation rather than rely on label claims.
Quantifying NMN requires methods that separate it from structurally similar compounds such as nicotinamide, nicotinamide riboside, and NAD+. Common approaches include high-performance liquid chromatography coupled with ultraviolet detection, liquid chromatography with tandem mass spectrometry, capillary electrophoresis, and nuclear magnetic resonance for identity confirmation. Because NMN is polar and often present at low concentrations in biological samples, sample preparation can involve protein precipitation, solid-phase extraction, or derivatization. Isotope-labeled internal standards help correct for matrix effects and recovery losses. Reported concentrations depend heavily on the matrix, extraction protocol, and analytical platform.
Stability of NMN depends on physical form, temperature, moisture, light, and pH. The solid compound is generally more stable than aqueous solutions, which can degrade over time, especially when warm or exposed to extreme pH. Recommended laboratory storage is typically desiccated at −20 °C or below, protected from light, with containers sealed to limit moisture uptake. In solution, degradation products may include nicotinamide and related ribosides, and the rate varies with buffer composition and concentration. Analytical laboratories often prepare fresh solutions and validate stability for each method.
Inside cells, the enzyme nicotinamide phosphoribosyltransferase, or NAMPT, converts nicotinamide and a ribose-phosphate donor into NMN. A second enzyme, NMN adenylyltransferase, then converts NMN into NAD+. NAD+ participates in redox reactions and serves as a substrate for signaling enzymes such as sirtuins, PARPs, and CD38. Because NAD+ levels tend to decline with age in many organisms, NMN has drawn interest as a possible way to influence that decline. Whether oral NMN reliably raises NAD+ in human tissues, and whether any such change modifies disease risk, remain open research questions.
NMN is present in small amounts in some foods, including certain vegetables, fruits, and animal products, but food content varies widely and is not well standardized. In laboratory research, NMN is used as a tool compound to study NAD+ metabolism, mitochondrial function, and cellular stress responses. Animal studies have reported changes in NAD+ levels and various physiological measures after NMN administration, but species differences and study designs limit direct extrapolation to humans. Human trials have largely focused on safety, tolerability, and pharmacokinetics, with fewer studies examining clinical endpoints.
Nicotinamide mononucleotide, commonly abbreviated NMN, is a naturally occurring nucleotide. Its structure consists of a nicotinamide ring attached to a ribose sugar that carries a phosphate group. The molecular formula is C11H15N2O8P, and the molar mass is about 334.22 grams per mole. In cells, NMN is an intermediate in the salvage pathway that recycles nicotinamide to maintain NAD+ levels. It is not the same compound as NAD+, although it is a direct precursor in one enzymatic step.
Commercial NMN is produced through enzymatic or chemical routes, and the resulting material can vary in purity, counterion, and residual solvent content. Buyers typically rely on certificates of analysis, but independent verification through third-party laboratories provides stronger assurance. Regulatory treatment differs by country; in the United States, NMN has been subject to shifting guidance about its status as a dietary supplement, while other markets permit sales under local rules. No universal pharmacopeial monograph exists for NMN, so specifications often come from suppliers, research protocols, or regional requirements.
Solid NMN is generally handled as a moisture-sensitive compound. Dry material stored desiccated at low temperature, protected from light, tends to remain stable for extended periods. Aqueous solutions are less stable and can undergo hydrolysis, especially at elevated temperature or alkaline pH. The anomeric form also matters: beta-NMN is the naturally occurring form, while alpha-NMN can appear as a synthetic impurity. Purity and storage conditions therefore influence both analytical results and experimental reproducibility.
Research on NMN includes cell studies, animal experiments, and a growing number of human trials. Many early findings come from mice, where changes in NAD+ levels and metabolic markers have been reported. Human data are more limited, and questions remain about effective routes of administration, tissue distribution, and long-term effects. Some trials measure NAD+ in blood or tissue, while others assess physical function or metabolic outcomes. Regulatory status differs between countries, and NMN is not universally approved as a dietary supplement or therapeutic agent.
Nicotinamide mononucleotide, commonly abbreviated NMN, is a naturally occurring nucleotide. Its structure combines a nicotinamide ring with a ribose sugar and a phosphate group. The compound appears in cells across many organisms as an intermediate in the production of nicotinamide adenine dinucleotide, or NAD+. Because NMN sits close to NAD+ in metabolism, it has drawn interest in biochemistry and aging research. The molecule is not a dietary essential nutrient in the classical sense, and its presence in food is generally low and variable.
== History == Setipiprant was initially researched by Actelion as a treatment for allergies and inflammatory disorders, particularly asthma, but despite being well tolerated in clinical trials and showing reasonable efficacy against allergen-induced airway responses in asthmatic patients, it failed to show sufficient advantages over existing drugs and was discontinued from further development in this application. However, following the discovery in 2012 that the prostaglandin D2 receptor (DP/PGD2) is expressed at high levels in the scalp of men affected by male pattern baldness, the rights to setipiprant were acquired by Kythera to develop the drug as a novel treatment for baldness. The favorable pharmacokinetics and relative lack of side effects seen in earlier clinical trials mean that fresh clinical trials for this new application can be conducted fairly quickly. As of 2015, setipiprant is currently under development by Allergan for the prevention of androgenic alopecia after their successful acquisition of Kythera.
The chain's origin can be traced to the Dwarf Grill (now the Dwarf House), a restaurant opened by S. Truett Cathy (the chain's former chairman and CEO) in 1946 in the Atlanta suburb of Hapeville, Georgia. The original store was located near the Ford Motor Company Atlanta Assembly Plant, a source of many of the restaurant's patrons for years. It was later remodeled, reopening in 2022. In 1961, after 15 years in the fast-food business, Cathy found a pressure fryer that could cook a chicken sandwich in the same time it took to cook a hamburger. Following this discovery, he registered the name Chick-fil-A, Inc. The company's trademarked slogan, "We Didn't Invent the Chicken, Just the Chicken Sandwich," refers to their flagship menu item, the Chick-fil-A chicken sandwich. Though Chick-fil-A was the first national chain to make a fast, fried chicken sandwich its flagship item, it has been shown that Cathy's claim to have "invented the chicken sandwich" is false. From 1964 to 1967, the sandwich was licensed to over fifty eateries, including Waffle House and the concession stands of the new Houston Astrodome. The Chick-Fil-A sandwich was withdrawn from sale at other restaurants when the first dedicated location opened in 1967, in the food court of the Greenbriar Mall in Atlanta. The chain expanded in the 1970s and early 1980s by opening new locations in suburban malls' food courts. The first freestanding location was opened April 16, 1986, on North Druid Hills Road in Atlanta, Georgia, and the company began to focus more on stand-alone units rather than food courts.
Football is the most popular sport in Germany. With more than 7 million official members, the German Football Association (Deutscher Fußball-Bund) is the largest single-sport organisation worldwide, and the German top league, the Bundesliga, attracts the second-highest average attendance of all professional sports leagues in the world. The German men's national football team won the FIFA World Cup in 1954, 1974, 1990, and 2014, the UEFA European Championship in 1972, 1980 and 1996, and the FIFA Confederations Cup in 2017. Germany is one of the world's leading motor sports countries, with constructors such as BMW and Mercedes playing prominent roles in international competition. Porsche has won the 24 Hours of Le Mans race 19 times, and Audi 13 times, as of April 2024. The driver Michael Schumacher has set many motor sport records, having won seven Formula One World Drivers' Championships. Sebastian Vettel is also among the most successful Formula One drivers of all time. German athletes historically have been successful contenders in the Olympic Games, ranking third in an all-time Olympic Games medal count when combining East and West German medals prior to German reunification. In 1936, Berlin hosted the Summer Games and the Winter Games in Garmisch-Partenkirchen. Munich hosted the Summer Games of 1972.
In Germany, rhinoplastic technique was refined by surgeons such as the Berlin University professor of surgery Karl Ferdinand von Gräfe (1787–1840), who published Rhinoplastik (Rebuilding the Nose, 1818) wherein he described 55 historical plastic surgery procedures, and his technically innovative free-graft nasal reconstruction (with a tissue-flap harvested from the patient's arm), and surgical approaches to eyelid, cleft lip, and cleft palate corrections. Dr. von Gräfe's protégé, the medical and surgical polymath Johann Friedrich Dieffenbach (1794–1847), who was among the first surgeons to anaesthetize the patient before performing the nose surgery, published Die Operative Chirurgie (Operative Surgery, 1845), which became a foundational medical and plastic surgical text (see strabismus, torticollis). Moreover, the Prussian Jacques Joseph (1865–1934) published Nasenplastik und sonstige Gesichtsplastik (Rhinoplasty and other Facial Plastic Surgeries, 1928), which described refined surgical techniques for performing nose-reduction rhinoplasty via internal incisions. In the United States, in 1887, the otolaryngologist John Orlando Roe (1848–1915) performed the first modern endonasal rhinoplasty (closed rhinoplasty) in order to treat saddle nose deformities. In America June 1894, a successful operation was reported to remove cartilage and "gratify the vanity" of a large nosed individual.
The two substrates of this enzyme are 15-oxodihydroprostaglandin E1 and oxidised nicotinamide adenine dinucleotide (NAD+). Its products are 15-oxoprostaglandin E1, reduced NADH, and a proton. The enzyme can also use nicotinamide adenine dinucleotide phosphate as an alternative cofactor. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-CH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is (5Z)-(15S)-11alpha-hydroxy-9,15-dioxoprostanoate:NAD(P)+ Delta13-oxidoreductase. Other names in common use include 15-oxo-Delta13-prostaglandin reductase, Delta13-15-ketoprostaglandin reductase, 15-ketoprostaglandin Delta13-reductase, prostaglandin Delta13-reductase, prostaglandin 13-reductase, and 15-ketoprostaglandin Delta13-reductase.
Sources: en.wikipedia.org
=== Surface plasmon resonance === The SBP-Tag has been used to reversibly immobilize recombinant proteins onto streptavidin-functionalized surfaces thereby permitting interaction assessment such as by surface plasmon resonance (SPR) techniques with re-use of the functionalized surface. SPR has also been used to compare the SBP-Tag with other streptavidin-binding peptides such as Strep-tag.
The downy woodpecker and hairy woodpecker look almost the same, as do some 'Chrysocolaptes and Dinopium flamebacks, the smoky-brown woodpecker and some Veniliornis species, and other Veniliornis species and certain "Picoides" and Piculus. In neither case are the similar species particularly close relatives. Many birds of Australia, like wrens and robins, look like Northern Hemisphere birds but are not related. Oilbirds like microbats and toothed whales developed sonar-like echolocation systems used for locating prey. The brain structure, forebrain, of hummingbirds, songbirds, and parrots responsible for vocal learning (not by instinct) is very similar. These types of birds are not closely related. Seriemas and secretary birds very closely resemble the ancient dromaeosaurid and troodontid dinosaurs. Both have evolved a retractable sickle-shaped claw on the second toe of each foot, both have feathers, and both are very similar in their overall physical appearance and lifestyle. Migrating birds like, Swainson's thrushes can have half the brain sleep with the other half awake. Dolphins, whales, Amazonian manatee and pinnipeds can do the same. Called unihemispheric slow-wave sleep. Brood parasitism, laying eggs in the nests of birds of other species, happens in types of birds that are not closely related. The charadriiform buttonquails closely resemble the galliform quails. Gallopheasants and junglefowl have similar tail-feathers but evolved them independently. Toucans and hornbills are very similar and occupy the same ecological niche, but are not closely related.
Asprey (1919–2005), American nuclear chemist known for actinide, lanthanide, rare-earth and fluorine chemistry Alán Aspuru-Guzik (born 1976), Mexican computational chemist known for variational quantum eigensolver Francis William Aston (1877–1945), British chemist and physicist known for mass spectroscopy, 1922 Nobel Prize in Chemistry Bengt Aurivillius (1918–1994), Swedish chemist known for his research in metal and mixed oxides. Karin Aurivillius (1920–1982), Swedish chemist who determined the crystal structures of many mercury compounds Amedeo Avogadro (1776–1856), Italian chemist and physicist, discovered Avogadro's law as a copmponent of noted for his contribution to molecular theory
Brincidofovir, sold under the brand name Tembexa, is an antiviral drug which was used to treat smallpox, prior to the global eradication of the disease in 1980. Brincidofovir is a prodrug of cidofovir. Conjugated to a lipid, the compound is designed to release cidofovir intracellularly, allowing for higher intracellular and lower plasma concentrations of cidofovir, effectively increasing its activity against dsDNA viruses, as well as oral bioavailability. The most common side effects include diarrhea, nausea, vomiting, and abdominal pain. It carries an FDA-mandated black box warning of an increased risk of death with extended use. Brincidofovir was approved for medical use in the United States in June 2021.
The curricula address subjects such as the biology of ageing, biomarkers, preventive medicine, healthspan, clinical assessment and the translation of ageing research into healthcare. The doctoral partnership with Ovidius University of Constanța began with a 2026 intake. The programme is described as a research doctorate in medicine with a specialization in longevity sciences and is not a physician qualification. Ovidius University is the degree-awarding institution. Dominik Thor serves as president of GCLS and professor of pharmacy. Luiza Spiru has held academic responsibilities within the institution, including involvement in longevity-medicine education and the Ovidius University doctoral collaboration.
Sources: en.wikipedia.org
Camptocormia, also known as bent spine syndrome (BSS), is a symptom of a multitude of diseases that is most commonly seen in the elderly. It is identified by an abnormal thoracolumbar spinal flexion, which is a forward bending of the lower joints of the spine, occurring in a standing position. In order to be classified as BSS, the anterior flexion (the lower back bending) must reach 45 degrees anteriorly. This classification differentiates it from a similar syndrome known as kyphosis. Although camptocormia is a symptom of many diseases, there are two common origins: neurological and muscular. Camptocormia is treated by alleviating the underlying condition causing it through therapeutic measures or lifestyle changes.
A leading case on (b) limiting production is AstraZeneca plc v Commission, where a drug company was fined €60 million for misleading public authorities to secure a longer patent for a medicine it called Losec, so limiting public use. In 2022, in Google LLC v Commission the General Court upheld a €4.125 billion fine against Google for the "obstruction of development and distribution of competing Android operating systems" by paying manufacturers to not install any version other than Google's own. Refusal to supply goods or services may also be abusive, as in Commercial Solvents Corporation v Commission where the subsidiary of CSC stopped selling an ingredient for a drug to combat tuberculosis to a competitor after it itself entered the drug market. Similarly in Microsoft Corp v Commission, Microsoft was fined €497 million for, among other things, refusing to give Sun Microsystems and other competitors information needed to build servers after Microsoft itself entered the server market.
There are several diagnostic and classification criteria have been proposed for dermatomyositis. Contemporary approaches generally combine clinical features with myositis-specific and myositis-associated autoantibody testing, supported by complementary laboratory, imaging, histopathologic, and electrophysiologic investigations. Some criteria are designed to establish a broad syndromic diagnosis of DM, whereas others provide greater granularity by identifying distinct autoantibody-defined clinical subsets. Despite these differences, the principal diagnostic features include:
=== Surface pressure and surface tension === There is a two-dimensional analog of pressure – the lateral force per unit length applied on a line perpendicular to the force. Surface pressure is denoted by π:
Sources: en.wikipedia.org
Solid NMN is generally stored in a sealed container at -20 °C or below, protected from light and moisture. Some suppliers recommend a desiccant and inert gas. Aqueous solutions are less stable and are often prepared fresh.
Liquid chromatography-mass spectrometry and nuclear magnetic resonance spectroscopy are common identity tests. HPLC with ultraviolet detection can assess purity by peak area. Results are usually compared with a certified reference standard.
Degradation can reduce the amount of intact NMN and create related impurities. Storage conditions and handling therefore affect measured purity and experimental reproducibility. Stability data also inform labeling and shelf-life claims.
NMN is nicotinamide mononucleotide, a nucleotide intermediate in NAD+ biosynthesis. It occurs naturally in cells and is also produced commercially as a supplement ingredient.